{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:08:31Z","timestamp":1778692111289,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.yexcr.2025.114752","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:41:25Z","timestamp":1757572885000},"page":"114752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hyperglycemia promotes tumor immune evasion via B7-H4 upregulation in ovarian cancer"],"prefix":"10.1016","volume":"452","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyuan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114752_bib1","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.tem.2024.04.013","article-title":"Microbiome dynamics in immune checkpoint blockade","volume":"35","author":"Kim","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.yexcr.2025.114752_bib2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tips.2024.04.006","article-title":"Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities","volume":"45","author":"Konen","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.yexcr.2025.114752_bib3","doi-asserted-by":"crossref","first-page":"Itc17","DOI":"10.7326\/AITC202402200","article-title":"Immune-related adverse events of immune checkpoint inhibitors","volume":"177","author":"Ramos-Casals","year":"2024","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.yexcr.2025.114752_bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","article-title":"Towards targeting the breast cancer immune microenvironment","volume":"24","author":"Harris","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2025.114752_bib5","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-22-3116","article-title":"Type 2 diabetes mellitus and efficacy outcomes from immune checkpoint blockade in patients with cancer","volume":"29","author":"Cortellini","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114752_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/cei.13424","article-title":"Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes","volume":"200","author":"Quandt","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.yexcr.2025.114752_bib7","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2025.114752_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155918","article-title":"Decreased leukocyte exhaustion is associated with decreased IFN-\u03b2 and increased \u03b1-defensin-1 levels in type-2 diabetes","volume":"156","author":"Shruthi","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.yexcr.2025.114752_bib9","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41419-023-06146-8","article-title":"Hepatic T-cell senescence and exhaustion are implicated in the progression of fatty liver disease in patients with type 2 diabetes and mouse model with nonalcoholic steatohepatitis","volume":"14","author":"Sim","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114752_bib10","article-title":"Tuning immune-cold tumor by suppressing USP10\/B7-H4 proteolytic axis reinvigorates therapeutic efficacy of ADCs","volume":"11","author":"Zeng","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.yexcr.2025.114752_bib11","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.cell.2024.06.012","article-title":"Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance","volume":"187","author":"Yu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2025.114752_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2019.104008","article-title":"B7-H4, a promising target for immunotherapy","volume":"347","author":"Wang","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.yexcr.2025.114752_bib13","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1158\/1078-0432.CCR-23-1079","article-title":"A B7-H4-Targeting antibody-drug conjugate shows antitumor activity in PARPi and platinum-resistant cancers with B7-H4 expression","volume":"30","author":"Gitto","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114752_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101007","article-title":"B7-H4 reduces the infiltration of CD8+T cells and induces their anti-tumor dysfunction in gliomas","volume":"54","author":"Qi","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.yexcr.2025.114752_bib15","article-title":"The role of B7-H4 in ovarian cancer immunotherapy: current status, challenges, and perspectives","volume":"15","author":"Zhou","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114752_bib16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.semcancer.2022.02.010","article-title":"Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer","volume":"86","author":"Wang","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexcr.2025.114752_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40425-019-0627-8","article-title":"Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFN\u03b3 receptor signaling","volume":"7","author":"Marijt","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.yexcr.2025.114752_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fimmu.2017.00330","article-title":"Immunometabolic regulations mediated by coinhibitory receptors and their impact on T cell immune responses","volume":"8","author":"Patsoukis","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114752_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11071037","article-title":"AP-1 transcription factors as regulators of immune responses in cancer","volume":"11","author":"Atsaves","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.yexcr.2025.114752_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1224892","article-title":"The potential of activator protein 1 (AP-1) in cancer targeted therapy","volume":"14","author":"Song","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114752_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117225","article-title":"A multi-omics approach to reveal critical mechanisms of activator protein 1 (AP-1)","volume":"178","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexcr.2025.114752_bib22","article-title":"DNA or protein methylation-dependent regulation of activator Protein-1 function","volume":"10","author":"Kim","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2025.114752_bib23","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s43018-023-00635-7","article-title":"PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma","volume":"4","author":"Wartewig","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.yexcr.2025.114752_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.917169","article-title":"Latent autoimmune diabetes in adults (LADA): from immunopathogenesis to immunotherapy","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.yexcr.2025.114752_bib25","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1158\/2767-9764.CRC-23-0468","article-title":"Epithelial expressed B7-H4 drives differential immunotherapy response in Murine and Human breast cancer","volume":"4","author":"Wescott","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.yexcr.2025.114752_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2022.104755","article-title":"B7-H4 expression promotes non-small cell lung cancer progression via AMPK\/mTOR signaling","volume":"125","author":"Li","year":"2022","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexcr.2025.114752_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16142519","article-title":"B7H4 role in solid cancers: a review of the literature","volume":"16","author":"Dawidowicz","year":"2024","journal-title":"Cancers (Basel)"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725003520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725003520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T04:15:48Z","timestamp":1758687348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725003520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0014482725003520"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114752","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperglycemia promotes tumor immune evasion via B7-H4 upregulation in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114752"}}